Comment on: Efficacy and Safety of the Duodenojejunal Bypass Liner in Patients With Metabolic Syndrome. Not Yet the Time to Abandon the Duodenal-Jejunal Bypass Liner Concept

Ann Surg. 2021 Dec 1;274(6):e862-e863. doi: 10.1097/SLA.0000000000004744.
No abstract available

Publication types

  • Letter
  • Comment

MeSH terms

  • Bariatric Surgery*
  • Humans
  • Metabolic Syndrome*
  • Obesity, Morbid*